7th National VBP Round Venue Moved to Nanjing from Shanghai
In a departure from previous practice, the 7th national volume-based procurement (VBP) round will not...
Policy / Regulatory
Beijing Introduces White List System for Biomedical R&D Item Imports
Beijing has announced the introduction of a ‘white list’ system to facilitate the import of...
China’s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules
China’s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related...
CDE Releases 58th and 59th Batches of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 58th and 59th batches of chemical...
Scotland Reports First Case of ASHep-UA in Children, WHO Issues Guidelines
Scotland recorded its first case of acute severe hepatitis of unknown etiology in children (ASHep-UA)...
Boao Lecheng Sees Surge in Drug Use and Medical Tourism Amid Global Partnerships
The Boao Lecheng Medical Tourism Pilot Zone reported a significant increase in special drug and...
China Issues Monkeypox Diagnosis Guidelines Amid Global Outbreaks
China’s National Health Commission (NHC) has formulated and released the “Monkeypox Diagnosis and Treatment Guidelines”...
US Bipartisan Bill Seeks to Regulate Investments in Chinese High-Tech Firms
US senators are preparing a bipartisan bill that would require US investors targeting Chinese high-tech...
NHSA Releases Draft Proposals for NRDL Annual Renewal Process
The National Healthcare Security Administration (NHSA) has formulated and released draft proposals for rules covering...
Enhancing Clinical Trial Success: CDE’s New Adaptive Design Framework Opens for Comment
The newly proposed guidelines are designed to be applicable across a spectrum of confirmatory clinical...
Shanghai to Launch China’s Largest ADR Database, Enhancing Pharmaceutical Oversight
Shanghai is advancing towards a significant milestone in pharmaceutical safety with plans to establish the...
China Unveils TCM Development Guidelines: A Strategic Defense of Traditional Medicine
In a strategic move to assert the value and historical significance of Traditional Chinese Medicine...
China’s SFDA Mandates Official Position Rotation to Boost Transparency
China’s State Food and Drug Administration (SFDA) is poised to embrace a new era of...
Guangdong’s ‘Sunlight Purchase’ System Sparks Drug Pricing War and Uncovers Pricing Anomalies
Since 2007, Guangdong province’s medical facilities have utilized an online procurement system known as “Sunlight...
SFDA Embraces Transparency: Regular Press Briefings and Personnel Rotations Announced
China’s State Food and Drug Administration (SFDA) is gearing up for a transparency overhaul, with...